Gyeonggi-do, South Korea

Jen Young Cho


 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:

goldMedal1 out of 832,843 
Other
 patents

Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Inventor Spotlight: Jen Young Cho**

Introduction

Jen Young Cho is a talented inventor based in Gyeonggi-do, South Korea. With her innovative spirit, she has made a notable contribution to the field of biochemistry through her patent, which addresses significant challenges posed by transcription factors in various diseases.

Latest Patents

Jen's key patent is titled "Fusion protein having transcription factor transactivation-regulating domain and protein transduction domain, and transcription factor function inhibitor comprising the same." This invention focuses on a fusion protein that combines the transactivation-regulating domain (TMD) of a transcription factor with a protein transduction domain (PTD). The patent instructs on the creation of an inhibitor that targets the function of transcription factors and details a method for producing it. This revolutionary fusion protein is designed to effectively treat diseases associated with malfunctions or defects of transcription factors, showing promise for broader therapeutic applications.

Career Highlights

Throughout her career, Jen Young Cho has shown dedication to advancing scientific knowledge and developing innovative solutions. Her work in this area not only highlights her inventiveness but also her commitment to addressing complex medical challenges. She holds one patent, which illustrates her capability and expertise in biochemical innovations.

Collaborations

Jen has collaborated with notable professionals in her field, including San-Kyou Lee and Tae Yoon Park. Their joint efforts contribute to a rich environment of innovation and research, fostering advancements in biotechnology and therapeutic solutions.

Conclusion

Jen Young Cho stands out as a remarkable inventor whose work has significant implications for the treatment of diseases linked to transcription factor malfunctions. With her promising patent and collaborations, she continues to contribute effectively to the scientific community, demonstrating the potential impact of innovative thinking in solving critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…